Haleon (HLN) has submitted a bid for US dietary supplements maker Thorne as the consumer health company seeks to expand its presence in the US supplements market, Reuters reported Friday, citing unnamed people familiar with the matter.

Thorne, which L Catterton acquired for $680 million in 2023, is exploring a sale that has attracted strategic interest and could value the company at as much as $4 billion, the report said.

Reuters, citing sources, said Unilever (UL) did not bid for Thorne, despite being identified as a potential bidder in an earlier Financial Times report.

Haleon and Unilever did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)